00:08:23 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



Bellus Health Inc
Symbol BLU
Shares Issued 138,511,268
Close 2010-12-31 C$ 0.16
Market Cap C$ 22,161,803
Recent Sedar+ Documents

Bellus Health to sell Cdn subsidiary for $1-million

2011-01-04 09:40 ET - News Release

Mr. Roberto Bellini reports

ADVANCED ORTHOMOLECULAR RESEARCH ACQUIRES BELLUS HEALTH'S CANADIAN SUBSIDIARY OVOS NATURAL HEALTH

Bellus Health Inc. and Advanced Orthomolecular Research Inc. (AOR) have entered into a share purchase agreement with respect to Bellus Health's wholly owned Canadian subsidiary OVOS Natural Health Inc., and into a Canadian licence and supply agreement relating to Bellus Health's Vivimind, a patented natural health product that has been shown to support the specific area of the brain known as the hippocampus, a region responsible for memory and learning.

Pursuant to the share purchase agreement, AOR is acquiring all issued and outstanding shares of Bellus Health's wholly owned Canadian subsidiary OVOS Natural Health Inc. for a total consideration of $1-million, consisting of an upfront payment of $350,000 and of a payment of $650,000 contingent upon the successful completion of a pre-established milestone event expected to occur within 18 months of the closing of the transaction. Pursuant to the licence and supply agreement, Bellus Health is granting AOR exclusive distribution rights for Vivimind in Canada and will be supplying AOR with the product at a preagreed transfer price. AOR will be responsible for all marketing, distribution and sales activities of Vivimind in Canada. Bellus Health retains all rights to Vivimind in other jurisdictions worldwide. The licence and supply agreement also provides for up to $3-million in commercial milestone payments to Bellus Health should certain mutually agreed upon sales targets be achieved.

"Following the issuance by Health Canada of a natural health product number (NPN) for Vivimind in September, 2010, we are pleased to enter into a licence and supply agreement for Canada with a leading provider of innovative nutraceuticals such as AOR," said Roberto Bellini, president and chief executive officer of Bellus Health. "This transaction further complements Bellus Health's strategy to focus on our core development expertise while allowing strong strategic partners to commercialize our innovative products. Following the similar partnership concluded recently with FB Health for the Italian market, this is a model that we are seeking to reproduce in other territories worldwide," he added.

"AOR has always put overriding emphasis on providing health practitioners and patients with science-backed natural health products. Vivimind is scientifically proven to help support the hippocampus, the specific area of the brain responsible for memory and learning," said Clark Sayer, chief operating officer of AOR. "Vivimind is a perfect addition to our portfolio of innovative nutraceutical products. Our team is looking forward to develop Vivimind to its full market potential in Canada," concluded Dr. Traj Nibber, president and founder of AOR.

About Vivimind

Vivimind is scientifically proven to help support the specific area of the brain known as the hippocampus, a region responsible for memory and learning. The active ingredient behind Vivimind, homotaurine, is a naturally occurring amino acid with unique properties found in certain seaweed. Vivimind is intended to be used in normal aging adults.

Vivimind was subject to over 15 years of significant scientific research, including clinical testing in over 2,000 individuals in European, American and Canadian medical centres. In a large controlled clinical study, Vivimind was shown to reduce by 68 per cent the hippocampus volume loss in Alzheimer's disease patients over 18 months. Regulatory approvals for the commercial sale of Vivimind were obtained in Italy and in Spain in 2009, and a natural health product number was issued by Health Canada for Vivimind in September of 2010.

About Advanced Orthomolecular Research

Advanced Orthomolecular Research (AOR) has an established reputation as the most advanced supplement formulator in Canada. AOR consistently puts science-backed vitamin supplements and natural health products into the hands of health practitioners and into the lives of patients, insisting on solid science and real-world outcomes. AOR's portfolio of products includes over 160 vitamin supplements and natural health products.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.